Sage Journals: Discover world-class research

Free access

Case report

First published 2024-1

Ponesimod-Associated Macular Edema: Onset and Resolution

Hartej Singh, Kush Patel, Alexander Port

Journal of VitreoRetinal Diseases

Free access

Review article

First published 2016-1

Ponesimod,a selective S1P1 receptor modulator: a potential treatment for multiple sclerosis and other immune-mediated diseases

Daniele D’Ambrosio, Mark S. Freedman, Joerg Prinz

Sage Open Chronic Disease

Retricted access

Review article

First published 2023-8

Ponesimod: An Oral Second-Generation Selective Sphingosine 1-Phosphate Receptor Modulator for the Treatment of Multiple Sclerosis

Amal Alnaif, Isabelle Oiler, Manoranjan S. D’Souza

Annals of Pharmacotherapy

Retricted access

Research article

First published 2024-04

Efficacy and Safety of Ponesimod Compared with Teriflunomide in Female Patients with Relapsing Multiple Sclerosis: Findings from the Pivotal OPTIMUM Study

Robyn R. Jones, Ibrahim Turkoz, Maria Ait-Tihyaty [...]

Journal of Women's Health

Open access

Research article

First published 2024

Comparative effectiveness and safety of ozanimod versus other oral DMTs in relapsing-remitting multiple sclerosis: a synthesis of matching-adjusted indirect comparisons

Damemarie Paul, Elyse Swallow, Oscar Patterson-Lomba [...]

Therapeutic Advances in Neurological Disorders

Open access

Review article

First published 2019

Progressive multiple sclerosis: latest therapeutic developments and future directions

Simon Faissner, Ralf Gold

Therapeutic Advances in Neurological Disorders

Open access

Review article

First published 2023

Disease-modifying therapies for relapsing/active secondary progressive multiple sclerosis – a review of population-specific evidence from randomized clinical trials

Antonios Bayas, Monika Christ, Simon Faissner [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Review article

First published 2026

Effect of Sphingosine-1-Phosphate Receptor Modulators on Insulin Resistance: A Review

Sandra Caíña López, Luciano Martínez Martínez, Andrea Bartolomé Figueroa [...]

Annals of Pharmacotherapy

Open access

Research article

First published 2023-3

The relevance of fatigue to relapse rate in multiple sclerosis: Applying patient preference data to the OPTIMUM trial

Robert J Fox, Tommi Tervonen, Andrea Phillips-Beyer [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2026

Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry

Andrea Surcinelli, Tomas Kalincik, Izanne Roos [...]

Therapeutic Advances in Neurological Disorders

Search results